Petra Windmolders

1.7k total citations
24 papers, 1.3k citations indexed

About

Petra Windmolders is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Petra Windmolders has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Molecular Biology and 8 papers in Hepatology. Recurrent topics in Petra Windmolders's work include Liver Disease Diagnosis and Treatment (12 papers), Drug Transport and Resistance Mechanisms (4 papers) and Diet, Metabolism, and Disease (4 papers). Petra Windmolders is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Drug Transport and Resistance Mechanisms (4 papers) and Diet, Metabolism, and Disease (4 papers). Petra Windmolders collaborates with scholars based in Belgium, Germany and Spain. Petra Windmolders's co-authors include Frederik Nevens, Jos van Pelt, Ingrid Vander Elst, Jonel Trebicka, Len Verbeke, Ricard Farré, Wim Laleman, Sabine Klein, Chris Verslype and Tim Vanuytsel and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Petra Windmolders

24 papers receiving 1.3k citations

Peers

Petra Windmolders
Svenja Sydor Germany
Natalia Rosso Italy
Julia Wattacheril United States
Monika Rau Germany
Kei Moriya Japan
Tomoki Nakajima Japan
Rhiannon N. Hardwick United States
Qing Pang China
Yuichi Yamazaki Japan
Yuemin Nan China
Svenja Sydor Germany
Petra Windmolders
Citations per year, relative to Petra Windmolders Petra Windmolders (= 1×) peers Svenja Sydor

Countries citing papers authored by Petra Windmolders

Since Specialization
Citations

This map shows the geographic impact of Petra Windmolders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Windmolders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Windmolders more than expected).

Fields of papers citing papers by Petra Windmolders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Windmolders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Windmolders. The network helps show where Petra Windmolders may publish in the future.

Co-authorship network of co-authors of Petra Windmolders

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Windmolders. A scholar is included among the top collaborators of Petra Windmolders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Windmolders. Petra Windmolders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bird, Matthew, Petra Windmolders, Peter de Witte, et al.. (2022). Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction. Molecular Metabolism. 63. 101537–101537. 24 indexed citations
2.
Bird, Matthew, Petra Windmolders, Ingrid Vander Elst, et al.. (2019). Oxygraphy Versus Enzymology for the Biochemical Diagnosis of Primary Mitochondrial Disease. Metabolites. 9(10). 220–220. 4 indexed citations
3.
Brucker, Katrijn De, Matthew Bird, Petra Windmolders, et al.. (2018). Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33. Peptides. 109. 33–38. 8 indexed citations
4.
Chen, Feng, Louis Libbrecht, Ingrid Vander Elst, et al.. (2017). Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease. World Journal of Gastroenterology. 23(30). 5499–5499. 10 indexed citations
5.
Verbeek, Jef, Pascal Spincemaille, Ilse Vanhorebeek, et al.. (2017). Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice. Lipids in Health and Disease. 16(1). 46–46. 16 indexed citations
6.
Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2016). FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Scientific Reports. 6(1). 33453–33453. 183 indexed citations
7.
Dekervel, Jeroen, Petra Windmolders, Diether Lambrechts, et al.. (2016). Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response. Translational Oncology. 10(1). 59–69. 40 indexed citations
8.
Plessis, Johannie du, Hannelie Korf, Jos van Pelt, et al.. (2016). Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. PLoS ONE. 11(12). e0166048–e0166048. 64 indexed citations
9.
Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2016). In Toxic Cirrhotic Rats, the FXR Agonist Obeticholic Acid Reduces Liver Fibrosis Indirectly via an Anti-Inflammatory Effect in Liver Sinusoidal Endothelial Cells and Kupffer Cells. Journal of Hepatology. 64(2). S141–S141. 1 indexed citations
10.
Dekervel, Jeroen, Dušan Popović, Hannah van Malenstein, et al.. (2016). A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma. Translational Oncology. 9(2). 139–146. 6 indexed citations
11.
Verbeke, Len, Ricard Farré, Bert Verbinnen, et al.. (2015). The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats. American Journal Of Pathology. 185(2). 409–419. 170 indexed citations
12.
Plessis, Johannie du, Jos van Pelt, Hannelie Korf, et al.. (2015). Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology. 149(3). 635–648.e14. 251 indexed citations
13.
Verbeke, Len, Inge Mannaerts, Robert Schierwagen, et al.. (2015). P0445 : Obeticholic acid, an FXR agonist, reduces hepatic fibrosis in a rat model of toxic cirrhosis. Journal of Hepatology. 62. S479–S479. 1 indexed citations
14.
Verbeek, Jef, Matthias Lannoo, Eija Pirinen, et al.. (2014). Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. Gut. 64(4). 673–683. 65 indexed citations
15.
Spincemaille, Pascal, Hamed Alborzinia, Jeroen Dekervel, et al.. (2014). The Plant Decapeptide OSIP108 Can Alleviate Mitochondrial Dysfunction Induced by Cisplatin in Human Cells. Molecules. 19(9). 15088–15102. 3 indexed citations
16.
Azaza, Mohamed Salah, et al.. (2013). Cytotoxicity evaluation and antioxidant enzyme expression related to heavy metals found in tuna by-products meal: An in vitro study in human and rat liver cell lines. Experimental and Toxicologic Pathology. 65(7-8). 1025–1033. 28 indexed citations
17.
Verbeke, Len, Ricard Farré, Jonel Trebicka, et al.. (2013). Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology. 59(6). 2286–2298. 213 indexed citations
18.
Malenstein, Hannah van, Jeroen Dekervel, Chris Verslype, et al.. (2012). Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth. Cancer Letters. 329(1). 74–83. 149 indexed citations
19.
Verslype, Chris, Hannah van Malenstein, Jeroen Dekervel, et al.. (2012). Resistance development after long-term sorafenib exposure in hepatocellular cancer cell lines and risk of rebound growth and epithelial to mesenchymal transition.. Journal of Clinical Oncology. 30(4_suppl). 216–216. 14 indexed citations
20.
Malenstein, Hannah van, et al.. (2011). Characterization of a cell culture model for clinically aggressive hepatocellular carcinoma induced by chronic hypoxia. Cancer Letters. 315(2). 178–188. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Svenja Sydor Breakdown of academic impact, for papers by Natalia Rosso Breakdown of academic impact, for papers by Julia Wattacheril Breakdown of academic impact, for papers by Monika Rau Breakdown of academic impact, for papers by Kei Moriya Breakdown of academic impact, for papers by Tomoki Nakajima Breakdown of academic impact, for papers by Rhiannon N. Hardwick Breakdown of academic impact, for papers by Qing Pang Breakdown of academic impact, for papers by Yuichi Yamazaki Breakdown of academic impact, for papers by Yuemin Nan
Rankless by CCL
2026